Surgical treatment of intracranial Erdheim-Chester disease

Alex Alfieri1, Roberto Gazzeri, Marcelo Galarza

  • 1Department of Neurological Surgery, Martin-Luther University Halle-Wittenberg, Halle, Germany. alex.alfieri@medizin.uni-halle.de

Insights

Erdheim-Chester disease (ECD) is a rare non-Langerhans histiocytosis. Intracranial ECD, though rare, presents with neurological symptoms and its treatment remains controversial.

Area of Science:

  • Neurology
  • Oncology
  • Histiocytosis

Background:

  • Erdheim-Chester disease (ECD) is a rare systemic non-Langerhans histiocytosis affecting multiple organs.
  • Intracranial involvement in ECD is infrequent, with limited cases documented in international literature.
  • Clinical manifestations include leg pain, exophthalmos, and diabetes insipidus (DI), with neurological symptoms often involving DI and cerebellar signs.

Purpose of the Study:

  • To review the clinical presentation, radiological and histological characteristics, and natural history of intracranial Erdheim-Chester disease.
  • To summarize the diagnostic and therapeutic approaches for central nervous system ECD.
  • To highlight the role of surgical interventions in the diagnosis and management of intracranial ECD.

Main Methods:

  • Literature review of intracranial Erdheim-Chester disease cases.
  • Analysis of clinical presentation, radiological findings, and histological characteristics.
  • Evaluation of treatment strategies, including surgical resection and radiation therapy.

Main Results:

  • Central nervous system involvement in ECD is rare, with only 27 reported patients.
  • Diabetes insipidus and cerebellar signs are the most common neurological symptoms.
  • Intracranial surgical procedures were performed in 11 patients, serving as the initial diagnostic method in seven.

Conclusions:

  • Intracranial Erdheim-Chester disease is a rare manifestation of a multi-systemic disorder.
  • The diagnosis and management of intracranial ECD, particularly surgical interventions, require careful consideration due to controversial treatment options.
  • Further research is needed to establish optimal treatment protocols for intracranial ECD.